Concepedia
Statistics
Publications
1
Citations
68
H-Index
Active since
2019
J.E. Gray is an author specializing in tyrosine kinase inhibitors, oncology, and cancer pharmacology.
Publications per year
2019–2019
Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis
Sendhilnathan Ramalingam, J.E. Gray, Yuichiro Ohe et al. · Annals of Oncology · 2019 · 68 citations · Full text
Medicine, Oncology, Pharmacology +8
1–1 of 1